Medical Advocates
HCV Infection/Disease
  Drugs  
General Reports              Thalidomide
 Amantadine                    Rituximab                
Peg Interferon-Alfa-2a     Tacrolimus  
Peg Interferon-Alfa-2b     Cyclosporine
 Ribavirin                          Alternative Therapies              
Interferon                         Investigational Therapies                  
Rifampin                          Post-Transplant Drugs             
Gammaglobulin              Alternative Therapies   
Immunoglobulin
 Meloxicam
Nevirapine
 Erythropoietin
 Corticosteroids
 Valproic Acid




 
HCV Main Page Main New/Newsworthy   Home Page    
Last Update:  March 18, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
 

     Journal Papers, Abstracts, and Commentaries

 
New data and recommendations of antiviral therapy of chronic hepatitis B and C.
 Niederau C.
Internist (Berl). 2008 Mar 15
Abstract
 
The emerging field of HCV drug resistance.
 Koev G, Kati W.
Expert Opin Investig Drugs. 2008 Mar;17(3):303-19.
 Abstract
 
Treatment regimens for patients with chronic hepatitis C.
 Trapero-Marugan M, González-Moreno L, Chaparro-Sánchez M, et al
Minerva Gastroenterol Dietol. 2008 Jun;54(2):209-17.
 Abstract
 
Complementary and alternative medicine use by patients chronically infected with hepatitis
C virus.
 White CP, Hirsch G, Patel S, et al
Can J Gastroenterol. 2007 Sep;21(9):589-95
 Abstract
 
Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders:
an international, multicenter cohort study.
Posthouwer D, Yee TT, Makris M, et al
 J Thromb Haemost. 2007 Aug;5(8):1624-1629.
 Abstract
 
Glucose Abnormalities Are an Independent Risk Factor for Nonresponse to Antiviral Treatment in
Chronic Hepatitis C.
Lecube A, Hernández C, Simó R, et al
 Am J Gastroenterol. 2007 Jul 7;
 Abstract
 
Viral determinants of resistance to treatment in patients with hepatitis C
 Wohnsland A, Hofmann WP, Sarrazin C.   
Clin Microbiol Rev. 2007 Jan;20(1):23-38.
 Abstract
 
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.
 Mehta SH, Lucas GM, Mirel LB, et al
AIDS. 2006 Nov 28;20(18):2361-9.
 Abstract
 
Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis:
A long-term follow-up study.
 Saadoun D, Resche-Rigon M, et al 
Arthritis Rheum. 2006 Oct 30;54(11):3696-3706
Abstract
 
Antiviral treatment of hepatitis C.
 Toniutto P, Fabris C, Pirisi M.
Expert Opin Pharmacother. 2006 Oct;7(15):2025-35.
 Abstract
 
Effectiveness of Antiviral Therapy in Patients with Chronic Hepatitis C Treated by Private
Practice Gastroenterologists.
Hofmann WP, Bock H, Weber C, et al
 Z Gastroenterol. 2006 Jan;44(1):25-31.
Abstract

The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based
approach.
 Camma C, Di Bona D, Craxi A. 
Curr Pharm Des. 2004;10(17):2123-30.
 Abstract
Erythropoietin
 
     Journal Papers, Abstracts, and Commentaries
 
 
Clinical recommendations for the use of recombinant human erythropoietin in patients with
hepatitis C virus being treated with ribavirin.
 Sherman M, Cohen L, Cooper MA, et al 
Can J Gastroenterol. 2006 Jul;20(7):479-85.
Abstract

Epoetin alfa for the Treatment of Combination Therapy-Induced Hemolytic Anemia in
Patients Infected with Hepatitis C Virus.
 Rivkin AM, Chawla S. 
Pharmacotherapy. 2005 Jun;25(6):862-7
 Abstract 

Normal erythropoietin response in chronic hepatitis C patients with ribavirin-induced anaemia.
Durante Mangoni E, Marrone A, Saviano D
Antivir Ther. 2003 Feb;8(1):57-63
 Abstract
Corticosteroids
 

     Journal Papers, Abstracts, and Commentaries

  Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis
C-autoimmune hepatitis overlap syndrome.
 Petersen-Benz C, Kasper HU, Dries V, Goeser T.
Clin Gastroenterol Hepatol. 2004 May;2(5):440-3
 Abstract
Rifampin
 

Rifampin/Pyrazinamide

     Journal Papers, Abstracts, and Commentaries

  Severe hepatotoxicity associated with rifampin-pyrazinamide preventative therapy
requiring transplantation in an individual at low risk for hepatotoxicity.
 Kunimoto D, Warman A, Beckon A,  et al.
Clin Infect Dis. 2003 Jun 15;36(12):E158-61
 Abstract
Meloxicam
 

     Journal Papers, Abstracts, and Commentaries

  Eight-week oral administration of meloxicam, a non-steroidal anti-inflammatory drug, prevents
dose reduction of pegylated interferon alpha-2a in the treatment of chronic hepatitis C.
 Kagawa T, Shiozawa H, Kojima SI, et al 
Hepatol Res. 2007 Sep 6;
 Abstract
Nevirapine
 

     Journal Papers, Abstracts, and Commentaries

  Analysis of Severe Hepatic Events Associated with Nevirapine-Containing Regimens :
CD4+ T-Cell Count and Gender in Hepatitis C Seropositive and Seronegative Patients.
 Torti C, Costarelli S, De Silvestri A, et al 
Drug Saf. 2007;30(12):1161-9.
 Abstract
Valproic Acid
 

     Journal Papers, Abstracts, and Commentaries

  The safety of valproic Acid use for patients with hepatitis C infection.
Felker BL, Sloan KL, Dominitz JA, Barnes RF.
Am J Psychiatry 2003 Jan;160(1):174-8
 Abstract
Gammaglobulin
 

      Journal Papers, Abstracts, and Commentaries

  Fibrosis regression induced by intravenous gammaglobulin treatment.
 Amital H, Rewald E, Levy Y, et al.
Ann Rheum Dis 2003 Feb;62(2):175-177
 Abstract
Immunoglobulin
 
   Journal Papers, Abstracts, and Commentaries
 
  Prophylaxis of Hepatitis C with Intramuscular Immunoglobulin: Clinical and Economic Appraisal.
 Piazza M, Sagliocca L, Tosone G, et al
BioDrugs. 1999 Oct;12(4):291-300.
 Abstract
Thalidomide
 
   Journal Papers, Abstracts, and Commentaries
 
  Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and
ribavirin.
Milazzo L, Biasin M, Gatti N, et l
Am J Gastroenterol. 2006 Feb;101(2):399-402
 Abstract
 Tacrolimus
 
   Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation:
Effects on virus replication and recurrent hepatitis.
 Hilgard P, Kahraman A, Lehmann N, et al 
World J Gastroenterol. 2006 Feb 7;12(5):697-702.
 Paper
Cyclosporine
 
   Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation:
Effects on virus replication and recurrent hepatitis.
 Hilgard P, Kahraman A, Lehmann N, et al 
World J Gastroenterol. 2006 Feb 7;12(5):697-702.
 Paper
Rituximab
 
   Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C virus infection and rituximab therapy after renal transplantation.
 Fabrizi F, Martin P, Elli A, et al 
Int J Artif Organs. 2007 May;30(5):445-9.
 Abstract
Alternate Therapies
 

     Journal Papers, Abstracts, and Commentaries

 
High prevalence of potentially hepatotoxic herbal supplement use in patients with
fulminant hepatic failure
Estes JD, Stolpman D, Olyaei A 
Arch Surg. 2003 Aug;138(8):852-8.
 Abstract

The use of alternative medicine in the treatment of hepatitis C.
 Bean P
Am Clin Lab 2002 May;21(4):19-21
 Abstract

  
HCV Main Page Main New/Newsworthy   Home Page    

HCV Drugs